Hypoglycemia is the principal barrier for achieving optimal, let alone normal, glycemic control for indefinite periods of time in patients with type 1 diabetes and advanced insulin-requiring type 2 diabetes [181]. The gene discussed is INS; the disease is type 1 diabetes mellitus.